Silencing SIRT2, a sirtuin enzyme, reduces malignancy in deadly breast cancer subtype
Tuesday, November 1, 2016 - 07:51
in Health & Medicine
Silencing SIRT2, a member of the sirtuin family of enzymes, reduces the invasiveness of basal-like breast cancer cells in culture and inhibits tumor growth in mice, according to new research.